Table 2.
Composite end point | ESKD | 50 % reduction of eGFR | |
---|---|---|---|
All | 90 | 50 | 40 |
Quartile 1 | 8 (8.9) | 1 (2.0) | 7 (17.5) |
Quartile 2 | 18 (20.0) | 5 (10.0) | 13 (32.5) |
Quartile 3 | 32 (35.6) | 14 (28.0) | 18 (45.0) |
Quartile 4 | 32 (35.6) | 30 (60.0) | 2 (5.0) |
Data are depicted as number of patients (% of total)
ESKD end-stage kidney disease, eGFR estimated glomerular filtration rate